Related Experiment Videos

High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors

N Inoue1, R K Hirata, D W Russell

  • 1Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington 98195-7720, USA.

Journal of Virology
|August 10, 1999
PubMed

Insights

Adeno-associated virus (AAV) vectors enable efficient gene targeting in human cells, correcting mutations with high fidelity. This breakthrough in gene correction offers broad therapeutic potential for various genetic disorders.

Area of Science:

  • Molecular Biology
  • Genetics
  • Gene Therapy

Background:

  • Conventional gene targeting in mouse embryonic stem cells shows limited success in normal primary human cells.
  • Inefficiencies in DNA transfer and low homologous recombination rates hinder gene targeting in many cell types.

Purpose of the Study:

  • To investigate the use of adeno-associated virus (AAV) vectors for gene targeting in human cells.
  • To demonstrate AAV's capability to correct various mutations with high fidelity and chromosomal position independence.

Main Methods:

  • Utilized a retroviral shuttle vector system to introduce and characterize target loci in human chromosomes.
  • Employed adeno-associated virus (AAV) vectors for gene targeting and mutation correction.

Main Results:

  • Achieved gene targeting rates close to 1% at the hypoxanthine phosphoribosyl transferase (HPRT) locus in normal human cells.
  • Demonstrated high-fidelity correction of multiple mutation types by AAV vectors, irrespective of chromosomal location.
  • Observed varying gene targeting rates dependent on mutation type, suggesting involvement of cellular mismatch recognition.

Conclusions:

  • AAV-mediated gene targeting is effective in human cells, overcoming limitations of conventional methods.
  • The efficiency and versatility of AAV vectors suggest wide applicability for therapeutic gene correction in vivo and ex vivo.

Related Concept Videos